Tumor and organ uptake of Cu-64 labeled amatuximab, an anti-mesothelin antibody, in a nude mouse model bearing a shed antigen tumor by mathematical model simulation

被引：0
|
作者：
Lee, Jae-Ho [1 ]
机构：
[1] NIH, NMD, RIS, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 254卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
273
引用
下载
收藏
页数：2
相关论文
共 30 条
  • [1] Tumor and organ uptake of 64Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies
    Lee, Jae-Ho
    Kim, Heejung
    Yao, Zhengsheng
    Lee, Sung-Jin
    Szajek, Lawrence P.
    Grasso, Luigi
    Pastan, Ira
    Paik, Chang H.
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (11) : 880 - 886
  • [2] Tumor and organ uptake of 64Cu labeled MORAb-009, an anti-mesothelin antibody by PET Imaging and biodistribution studies
    Lee, Jae-Ho
    Kim, Heejung
    Yao, Zhengsheng
    Lee, Sung-Jin
    Szajek, Lawrence
    Grasso, Luigi
    Pastan, Ira
    Paik, Chang
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [3] Study on the efficacy of mesothelin targeting recombinant immunotoxins in a nude mouse model bearing shed antigen tumors by mathematical model simulation
    Lee, Jae-Ho
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [4] Internal Dosimetry of Cu-64 in a Computational Tumor-Bearing Mouse Model
    Witter, P. k
    Brandl, A.
    Bell, J. J.
    HEALTH PHYSICS, 2023, 125 (01): : 14 - 14
  • [5] Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody
    Shin, In Soo
    Lee, Sang-Myung
    Kim, Hyung Sub
    Yao, Zhengsheng
    Regino, Celeste
    Sato, Noriko
    Cheng, Kenneth T.
    Hassan, Raffit
    Campo, Melissa F.
    Albone, Earl F.
    Choyke, Peter L.
    Pastan, Ira
    Paik, Chang H.
    NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (08) : 1119 - 1127
  • [6] Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model
    Yuki Fujii
    Hirofumi Kamachi
    Fumihiko Matsuzawa
    Tatsuzo Mizukami
    Nozomi Kobayashi
    Moto Fukai
    Akinobu Taketomi
    Investigational New Drugs, 2021, 39 : 1256 - 1266
  • [7] Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model
    Fujii, Yuki
    Kamachi, Hirofumi
    Matsuzawa, Fumihiko
    Mizukami, Tatsuzo
    Kobayashi, Nozomi
    Fukai, Moto
    Taketomi, Akinobu
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (05) : 1256 - 1266
  • [8] Discrepancy Between Tumor Antigen Distribution and Radiolabeled Antibody Binding in a Nude Mouse Xenograft Model of Human Melanoma
    Kim, Yong-Il
    Paeng, Jin Chul
    Cheon, Gi Jeong
    Kang, Keon Wook
    Lee, Dong Soo
    Chung, June-Key
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2017, 32 (03) : 83 - 89
  • [9] Induced tumor fluorescence using fluorophore-tagged anti-tumor antigen antibodies in the nude mouse model - an example for use in humans
    Luilken, G.
    Xu, M.
    Hoffman, R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 322 - 322
  • [10] INFLUENCE OF CIRCULATING ANTIGEN ON THE BIODISTRIBUTION AND TUMOR-LOCALIZATION OF RADIOLABELED MONOCLONAL-ANTIBODY IN A HUMAN-TUMOR - NUDE-MOUSE XENOGRAFT MODEL
    PIMM, MV
    DURRANT, LG
    BALDWIN, RW
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (09): : 1325 - 1332
123